Multiple Sclerosis (MS)

2591 Words6 Pages

Multiple sclerosis (MS) is the interruption of signals of the nerve impulses due to the deterioration of the covering of the nerve fibers myelin sheath that covers the nerve fibers and axon in the (CNS) central nervous system and (SC) spinal cord (Compston & Coles, 2008). According to Goodman and Fuller (2015), the primary clinical manifestation of MS is visual deterioration (double vision, nystagmus, etc.) due to the affected optic nerve associated with demyelination of the cerebral cortex. Furthermore, weakness is due to the diminished impulses secondary to the damaged nerve fibers and axons of the spinal cord, sensory and balance deficits as well as fatigue (which occurs in the mid-afternoon) which contribute to the most disabling symptoms …show more content…

Therefore, Asano & Finlayson (2014) collected twenty-five Randomized Controlled Trials (RCT) data of comparing the effectiveness of educational programs, rehabilitation regimen and MS medications to help reduce fatigue related to MS. Fatigue is one of the most significant and afflictive manifestation of the disease with adverse implications for general function to well-being (Bakshi, Shaikh, Miletich, Czarnecki, Dmochowski, Henschel, 2000; Fisk, Ritvo, Ross, Haase, Marrie & Schlech, 1994; There are 1,499 participants included in the study; the group was divided into three groups and mostly were female with the age range of twenty-five to fifty-six years old related to MS. The group were distributed evenly and accordingly to the severity of the MS disability. The treatment provided in each group, including ten exercise program (supervised by a physiotherapist and occupational therapies), eight educational therapies (psychotherapies, behavioral) and seven MS medications (managed by nurses). The MS disability status of the patients based on the Kurtzke Expanded Disability Status Scale (Kurtzke, 1983; Kurtzke, 1984). Asano, et al. (2014) identified that the most favored method for measuring exercise and pharmacological treatment trial is Fatigue Disability Scale (FDS) due to the reliability of the outcome.
The validity of the study: There is a significant validity to the educational group due the …show more content…

The location of the inflammation or lesions in the brain may be able to determine the symptoms of a person with MS. The primary features of MS consist of voluntary tremor, ataxic dysarthria, and involuntary eye movement. Presently, there is no cure for MS, but there are various non- pharmacological and pharmacological treatment to help manage the relapses, exacerbations, preventing the increased disability, modifying/ controlling the progression of the disease process and for treating the symptoms of the illness (National Multiple Sclerosis Society, n.d.). The physiotherapist has an important role to our patients in maintaining their function, providing education and formulate numerous diverse strategies for effective physical therapy treatment and patient’s safety due to different MS drug cycles and its side

Open Document